Metabolic Syndrome and Non-Alcoholic Liver Disease
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Lipid Metabolism".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 4889
Special Issue Editors
Interests: metabolic syndrome; non-alcoholic liver disease; insulin resistance; fatty liver disease; obesity; type 2 diabetes; liver cirrhosis; dyslipidemia; NAFLD treatment; risk factors
Interests: autism spectrum disorder; Phelan-McDermid syndrome; cancer; overgrowth; liver disease; gut microbiota; COVID-19
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to provide a platform for researchers to present their latest findings and insights in the field of metabolic syndrome and non-alcoholic liver disease (NAFLD). The focus of this Special Issue is to explore the complex interplay between metabolic syndrome and NAFLD, shedding light on its underlying mechanisms, clinical implications, and potential therapeutic strategies.
This Special Issue welcomes contributions that address various aspects of metabolic syndrome and NAFLD, including (but not limited to) the pathophysiology, epidemiology, diagnostic tools, treatment modalities, and preventive measures. Research articles, reviews, and original studies that elucidate the link between metabolic syndrome and NAFLD, as well as those focusing on novel approaches for managing these interconnected conditions, are encouraged.
The purpose of this Special Issue is to foster a deeper understanding of the relationship between metabolic syndrome and NAFLD, considering the escalating global burden of both conditions. By gathering diverse perspectives and cutting-edge research, we aim to enhance the knowledge base and provide valuable insights for clinicians, researchers, and public health practitioners. Ultimately, we strive to facilitate the development of more effective strategies for the prevention, diagnosis, and management of metabolic syndrome and NAFLD, addressing the unmet clinical needs in this field.
Potential authors are invited to contribute original research articles, reviews, and commentaries that delve into the intricate links between metabolic syndrome and NAFLD, as well as propose innovative approaches for addressing these significant health challenges. We welcome submissions that offer new perspectives, present compelling data, and contribute to advancing the field's understanding of metabolic syndrome and NAFLD. Through this Special Issue, we aim to encourage dialogue, share best practices, and pave the way for improved clinical outcomes in these interconnected domains.
Prof. Dr. Mircea-Catalin Fortofoiu
Dr. Luigi Boccuto
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolic syndrome
- non-alcoholic fatty liver disease (NAFLD)
- insulin resistance
- obesity
- type 2 diabetes
- liver cirrhosis
- dyslipidemia
- NAFLD treatment
- hepatic steatosis
- cardiovascular risk
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.